FONAR Corporation

NASDAQ:FONR

Medical - Devices

Healthcare
$19.09 +0.00%

+$0.00 today

Market cap
$117.76M
Beta
0.95
P/E (TTM)
17.6
EPS (TTM)
$1.08
52W Low $13.62High $19.16

Volume 0.00M

Average 0.08M

FONR Weighted Avg Shares (Diluted)

Average shares outstanding including dilutive securities, used to calculate diluted EPS.

FONAR CorporationNASDAQ: FONR

Weighted Avg Shares (Diluted) · Q3 FY2026 · quarter ended Mar 2026

Weighted avg shares (diluted) growth accelerates

Q3 FY2026 weighted avg shares (diluted) of 6.3M shares rose 0.0% year over year, ahead of the -4.2% change in trailing-twelve-month weighted avg shares (diluted). Sequentially, it fell 1.7% from the prior quarter. Over 3 fiscal years it compounded at -0.7% a year.

Context

  • Weighted avg shares (diluted) increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +0.0% holds above the trailing-twelve-month pace of -4.2%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
6.3M-1.7% QoQ
Last fiscal yearJun 2025
6.55M+1.1% YoY
LTMMar 2026
6.39M-4.2% YoY
Weighted Avg Shares (Diluted) past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+0.0%——
1 year+1.1%——
3-year CAGR-0.7%——
5-year CAGR——
10-year CAGR——

Weighted Avg Shares (Diluted) history

Shares · from the income statement

Latest · FY2025
6.55M USD
Year-over-year change
+1.1%
4-year CAGR
-0.7%

Weighted Avg Shares (Diluted) vs competitors

How FONR compares with its peers on the latest reported figures

  • FONR's LTM Mar 2026 weighted avg shares (diluted) of 6.39M shares is the lowest of the 8 companies compared; the peer median is 41.45M shares.
  • Its year-over-year change of -4.2% is the 7th highest of 8, against a peer median of +14.8%.
  • Over three fiscal years its annual growth of -0.7% compares with a peer median of +10.2%.
FONR Competitors Peer median
Weighted Avg Shares (Diluted) for FONR and competitors
Company Period LTM YoY 3-year CAGR
HYPRHyperfine, Inc.LTM Mar 202687.25M +18.9%+10.2%
IFRXInflaRx N.V.LTM Mar 202668.86M +14.8%+15.0%
VANIVivani Medical, Inc.LTM Mar 202665.65M +15.7%+17.7%
APYXApyx Medical CorporationLTM Mar 202641.45M +15.9%+6.9%
LUNGPulmonx CorporationLTM Mar 202641.11M +4.5%+3.1%
ARTVArtiva Biotherapeutics, Inc.LTM Mar 202624.5M +1.8%+11.6%
RCELAVITA Medical, Inc.LTM Mar 202621.36M -17.9%+3.7%
FONRFONAR CorporationLTM Mar 20266.39M -4.2%-0.7%
Peer median (excluding FONR) 41.45M+14.8%+10.2%

Competitors are the stored peer set for FONR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue89.93M97.59M98.65M102.88M104.35M
Cost of Revenue46.46M50.58M52.9M57.74M61.44M
Gross Profit43.47M47.01M45.75M45.14M42.91M
Gross Margin48.3%48.2%46.4%43.9%41.1%
Research & Development1.64M1.49M1.57M1.74M1.58M
Selling, General & Admin0029.39M029.73M
Operating Expenses26.38M25.01M30.96M28.6M31.31M
Depreciation & Amortization4.08M4.54M8.8M4.6M4.7M
EBITDA22M27.65M24.61M23.94M18.5M
EBITDA Margin24.5%28.3%25.0%23.3%17.7%
Operating Income17.1M22.01M14.79M16.54M11.6M
Operating Margin19.0%22.6%15.0%16.1%11.1%
Interest Income00002.17M
Interest Expense248.67K346.55K50.13K77K25.61K
Other Income / Expenses567.72K761.69K969.33K2.73M2.18M
Income Before Tax17.67M22.77M15.76M19.27M13.78M
Pre-Tax Margin19.6%23.3%16.0%18.7%13.2%
Income Tax Expense3.99M5.53M3.63M5.17M3.11M
Net Income10.21M12.44M9.38M10.57M8.33M
Net Margin11.4%12.7%9.5%10.3%8.0%
EPS (Basic)1.471.781.351.561.26
EPS (Diluted)1.451.751.321.531.23
Weighted Avg Shares6.61M6.55M6.65M6.35M6.32M
Weighted Avg Shares (Diluted)6.74M6.68M6.77M6.48M6.55M

FONAR Corporation

NASDAQ:FONR

Intrinsic Alpha fair value

Locked

Current Price

$19.09

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.